These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9778658)
21. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets. Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480 [TBL] [Abstract][Full Text] [Related]
22. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo. Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160 [TBL] [Abstract][Full Text] [Related]
23. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors. Deliganis AV; Pierce PA; Peroutka SJ Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347 [TBL] [Abstract][Full Text] [Related]
24. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task. Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031 [TBL] [Abstract][Full Text] [Related]
25. Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Knapp DJ; Overstreet DH; Crews FT Brain Res; 1998 Jan; 782(1-2):1-10. PubMed ID: 9519243 [TBL] [Abstract][Full Text] [Related]
26. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Arnt J; Hyttel J Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390 [TBL] [Abstract][Full Text] [Related]
27. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain. Sumiyoshi T; Ichikawa J; Meltzer HY Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434 [TBL] [Abstract][Full Text] [Related]
28. Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats. McCreary AC; Handley SL J Psychopharmacol; 2000; 14(3):280-3. PubMed ID: 11106309 [TBL] [Abstract][Full Text] [Related]
29. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems. Uchitomi Y; Yamawaki S Psychopharmacology (Berl); 1993; 112(1):74-9. PubMed ID: 7871012 [TBL] [Abstract][Full Text] [Related]
30. Circadian rhythm in the hypothermic response to serotonin1A receptor agonist 8-OH-DPAT in rats. Lu JQ; Nagayama H Chronobiol Int; 1997 May; 14(3):267-73. PubMed ID: 9167887 [TBL] [Abstract][Full Text] [Related]
31. Effect of the repeated administration of (+/-)-3,4-methylenedioxymethamphetamine on the behavioral response of rats to the 5-HT1A receptor agonist (+/-)-8-hydroxy-(di-n-propylamino)tetralin. Granoff MI; Ashby CR Neuropsychobiology; 2001 Jan; 43(1):42-8. PubMed ID: 11150898 [TBL] [Abstract][Full Text] [Related]
32. Long-term sequential determination of behavioral ontogeny of 5-HT1A and 5-HT2 receptor functions in the rat. Darmani NA; Ahmad B J Pharmacol Exp Ther; 1999 Jan; 288(1):247-53. PubMed ID: 9862777 [TBL] [Abstract][Full Text] [Related]
33. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288 [TBL] [Abstract][Full Text] [Related]
34. Repeated cocaine administration does not affect 5-HT receptor subtypes (5-HT1A, 5-HT2) in several rat brain regions. Javaid JI; Sahni SK; Pandey SC; Davis JM Eur J Pharmacol; 1993 Jul; 238(2-3):425-9. PubMed ID: 8405113 [TBL] [Abstract][Full Text] [Related]
35. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats. Lund A; Mjellem N Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex. Compan V; Segu L; Buhot MC; Daszuta A Brain Res; 1998 Jun; 795(1-2):264-76. PubMed ID: 9622647 [TBL] [Abstract][Full Text] [Related]
37. Serotonin-induced 5-HT1A receptor desensitization in C6BU-1 glioma cells transfected with 5-HT1A receptor gene. Saitoh K; Mikuni M; Ikeda M; Yamazaki C; Tomita U; Takahashi K Neurosci Lett; 1995 Oct; 199(3):191-4. PubMed ID: 8577395 [TBL] [Abstract][Full Text] [Related]
38. Expression and modulation of 5-hydroxytryptamine1A receptors in P11 cells. Hensler JG; Cervera LS; Miller HA; Corbitt J J Pharmacol Exp Ther; 1996 Sep; 278(3):1138-45. PubMed ID: 8819496 [TBL] [Abstract][Full Text] [Related]
39. [On the Functional Cross-Talk between Brain 5-HT1A and 5-HT2A Receptors]. Naumenko VS; Bazovkina DV; Kondaurova EM Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(2):240-7. PubMed ID: 26080602 [TBL] [Abstract][Full Text] [Related]
40. A comparison of the effects of 8-OH-DPAT pretreatment of different behavioural responses to 8-OH-DPAT. O'Connell MT; Curzon G Eur J Pharmacol; 1996 Sep; 312(2):137-43. PubMed ID: 8894587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]